BACKGROUND: We sought to determine if type 2 diabetes mellitus (T2DM) was associated with accelerated decline in domain-specific measures of cognitive function and fine motor speed. METHODS:Women aged 65-80 years who were enrolled in a clinical trial of postmenopausal hormone therapy were grouped as having T2DM (n=179) or not (n=1984) and followed for an average of 5 years with annual standardized assessments of domain-specific cognitive function. Mean patterns of cognitive measures over time were contrasted between groups using general linear models and Wald tests, with varying levels of covariate adjustment. The influences of age at onset, use of oral medications, and use of insulin were also examined. RESULTS: T2DM was associated with mean deficits of 0.2-0.4 standard deviations (SD) across follow-up in most cognitive domains. Consistent evidence that rates of decline were accelerated among women with T2DM was evident only for verbal knowledge and verbal memory (p<0.05). Decrements in fine motor speed, but no measure of cognitive function, were greater for women with earlier onset T2DM. Use of oral diabetes medications was associated with better relative cognitive function. CONCLUSIONS: In these women, T2DM was associated with cognitive deficits in most domains. Relative deficits in verbal knowledge and verbal memory may continue to increase after deficits in other domains have stabilized. Relative deficits in fine motor speed may be greater among women with earlier onsets of T2DM. Use of insulin, which may reflect greater T2DM severity, was associated with relatively greater cognitive deficits.
RCT Entities:
BACKGROUND: We sought to determine if type 2 diabetes mellitus (T2DM) was associated with accelerated decline in domain-specific measures of cognitive function and fine motor speed. METHODS:Women aged 65-80 years who were enrolled in a clinical trial of postmenopausal hormone therapy were grouped as having T2DM (n=179) or not (n=1984) and followed for an average of 5 years with annual standardized assessments of domain-specific cognitive function. Mean patterns of cognitive measures over time were contrasted between groups using general linear models and Wald tests, with varying levels of covariate adjustment. The influences of age at onset, use of oral medications, and use of insulin were also examined. RESULTS: T2DM was associated with mean deficits of 0.2-0.4 standard deviations (SD) across follow-up in most cognitive domains. Consistent evidence that rates of decline were accelerated among women with T2DM was evident only for verbal knowledge and verbal memory (p<0.05). Decrements in fine motor speed, but no measure of cognitive function, were greater for women with earlier onset T2DM. Use of oral diabetes medications was associated with better relative cognitive function. CONCLUSIONS: In these women, T2DM was associated with cognitive deficits in most domains. Relative deficits in verbal knowledge and verbal memory may continue to increase after deficits in other domains have stabilized. Relative deficits in fine motor speed may be greater among women with earlier onsets of T2DM. Use of insulin, which may reflect greater T2DM severity, was associated with relatively greater cognitive deficits.
Authors: Susan M Resnick; Laura H Coker; Pauline M Maki; Stephen R Rapp; Mark A Espeland; Sally A Shumaker Journal: Clin Trials Date: 2004 Impact factor: 2.486
Authors: Barbera van Harten; Joukje Oosterman; Dino Muslimovic; Bert-Jan Potter van Loon; Philip Scheltens; Henry C Weinstein Journal: Age Ageing Date: 2007-03 Impact factor: 10.668
Authors: Alan M Jacobson; Gail Musen; Christopher M Ryan; Nancy Silvers; Patricia Cleary; Barbara Waberski; Amanda Burwood; Katie Weinger; Meg Bayless; William Dahms; Judith Harth Journal: N Engl J Med Date: 2007-05-03 Impact factor: 91.245
Authors: Ellen Grober; Charles B Hall; Richard B Lipton; Alan B Zonderman; Susan M Resnick; Claudia Kawas Journal: J Int Neuropsychol Soc Date: 2008-03 Impact factor: 2.892
Authors: S A Shumaker; B A Reboussin; M A Espeland; S R Rapp; W L McBee; M Dailey; D Bowen; T Terrell; B N Jones Journal: Control Clin Trials Date: 1998-12
Authors: David C Steffens; Emeline Otey; George S Alexopoulos; Meryl A Butters; Bruce Cuthbert; Mary Ganguli; Yonas E Geda; Hugh C Hendrie; Ranga R Krishnan; Anand Kumar; Oscar L Lopez; Constantine G Lyketsos; Benjamin T Mast; John C Morris; Maria C Norton; Guerry M Peavy; Ronald C Petersen; Charles F Reynolds; Stephen Salloway; Kathleen A Welsh-Bohmer; Jerome Yesavage Journal: Arch Gen Psychiatry Date: 2006-02
Authors: Susan M Resnick; Pauline M Maki; Stephen R Rapp; Mark A Espeland; Robert Brunner; Laura H Coker; Iris A Granek; Patricia Hogan; Judith K Ockene; Sally A Shumaker Journal: J Clin Endocrinol Metab Date: 2006-03-07 Impact factor: 5.958
Authors: Jeff D Williamson; Michael E Miller; R Nick Bryan; Ronald M Lazar; Laura H Coker; Janice Johnson; Tali Cukierman; Karen R Horowitz; Anne Murray; Lenore J Launer Journal: Am J Cardiol Date: 2007-04-12 Impact factor: 2.778
Authors: Rachel Galioto; Michael L Alosco; Mary Beth Spitznagel; Gladys Strain; Michael Devlin; Ronald Cohen; Ross D Crosby; James E Mitchell; John Gunstad Journal: J Clin Exp Neuropsychol Date: 2015-04-15 Impact factor: 2.475
Authors: Marco Inzitari; Andrea Metti; Caterina Rosano; Cristina Udina; Laura M Pérez; Gabriela Carrizo; Joe Verghese; Anne B Newman; Stephanie Studenski; Andrea L Rosso Journal: Exp Gerontol Date: 2019-07-06 Impact factor: 4.032
Authors: Mark A Espeland; Roberta Diaz Brinton; JoAnn E Manson; Kristine Yaffe; Christina Hugenschmidt; Leslie Vaughan; Suzanne Craft; Beatrice J Edwards; Ramon Casanova; Kamal Masaki; Susan M Resnick Journal: Neurology Date: 2015-07-10 Impact factor: 9.910
Authors: Priya Palta; Andrea L C Schneider; Geert Jan Biessels; Pegah Touradji; Felicia Hill-Briggs Journal: J Int Neuropsychol Soc Date: 2014-02-20 Impact factor: 2.892
Authors: Jamaica R Rettberg; Ha Dang; Howard N Hodis; Victor W Henderson; Jan A St John; Wendy J Mack; Roberta Diaz Brinton Journal: Neurobiol Aging Date: 2016-01-29 Impact factor: 4.673
Authors: Eric M Ammann; James V Pottala; William S Harris; Mark A Espeland; Robert Wallace; Natalie L Denburg; Ryan M Carnahan; Jennifer G Robinson Journal: Neurology Date: 2013-09-25 Impact factor: 9.910
Authors: Priya Palta; Michelle C Carlson; Rosa M Crum; Elizabeth Colantuoni; A Richey Sharrett; Sevil Yasar; Richard L Nahin; Steven T DeKosky; Beth Snitz; Oscar Lopez; Jeff D Williamson; Curt D Furberg; Stephen R Rapp; Sherita Hill Golden Journal: J Gerontol A Biol Sci Med Sci Date: 2017-12-12 Impact factor: 6.053